These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35280)

  • 1. Mutagenicity of the non-carcinogenic dibenzylnitrosamine and an alpha-acetoxy derivative.
    Jacobson MK; Barton RA; Yoder SS; Sigh S; Lyle RE
    Cancer Lett; 1979 Feb; 6(2):83-7. PubMed ID: 35280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenicity of methylbenzylnitrosamine and its alpha-acetoxy derivatives.
    Tannenbaum SR; Kraft P; Baldwin J; Branz S
    Cancer Lett; 1977 May; 2(6):305-10. PubMed ID: 324607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicities of N-nitrosamines on Salmonella.
    Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T
    Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P; Gingell R
    Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of alpha-acetoxy derivatives of N-methyl-N-benzylnitrosamine and N,N-dibenzylnitrosamine in V79 cells: a comparison between methylating and benzylating mutagens.
    Huang Kohda K; Anjo T; Mochizuki M; Kawazoe Y; Okada M
    Gan; 1982 Aug; 73(4):517-21. PubMed ID: 7152191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of beta-oxidized N,N,-di-n-propylnitrosamine derivatives in S. typhimurium mediated by rat and hamster tissues.
    Camus A; Bertram B; Krüger FW; Malaveille C; Bartsch H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):293-302. PubMed ID: 136104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and DNA-damaging effects of N-(omega-acetoxyalkyl and omega-methoxycarbonylalkyl)-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines with an omega-functional group.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1980 Feb; 71(1):124-30. PubMed ID: 6769736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activation of dimethylnitrosamine and diethyl-nitrosamine in the host-mediated assay and the microsomal system.
    Malling HV
    Mutat Res; 1974 Dec; 26(6):465-72. PubMed ID: 4154402
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism and mutagenicity of N-nitrosohexamethyleneimine and its hydroxylated derivatives.
    Hecker LI; Saavedra JE; Andrews AW
    Teratog Carcinog Mutagen; 1983; 3(1):9-17. PubMed ID: 6132461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-derived N-nitroso compounds. III: Mutagenicity in S. typhimurium and in vitro induction of DNA single-strand breaks in rat hepatocytes by mononitrosocaffeidine and dinitrosocaffeidine.
    Erdinger L; Schmezer P; Razdan R; Kumar R; Spiegelhalder B; Preussmann R; Siddiqi M
    Mutat Res; 1993 Aug; 292(1):41-9. PubMed ID: 7688096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolic activation of N,N-dibutylnitrosamine in mutagenesis.
    Suzuki E; Mochizuki M; Wakabayashi Y; Okada M
    Gan; 1983 Feb; 74(1):51-9. PubMed ID: 6341155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mutagenicity of N-(alpha-acyloxy)alkyl-N-alkylnitrosamines in S. typhimurium: model compounds for metabolically activated N,N-dialkylnitrosamines.
    Camus AM; Wiessler M; Malaveille C; Bartsch H
    Mutat Res; 1978 Feb; 49(2):187-94. PubMed ID: 342933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.